GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clene Inc (FRA:84C) » Definitions » EV-to-EBIT

Clene (FRA:84C) EV-to-EBIT : -1.19 (As of May. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clene EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Clene's Enterprise Value is €49.41 Mil. Clene's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-41.57 Mil. Therefore, Clene's EV-to-EBIT for today is -1.19.

The historical rank and industry rank for Clene's EV-to-EBIT or its related term are showing as below:

FRA:84C' s EV-to-EBIT Range Over the Past 10 Years
Min: -44.27   Med: -4.03   Max: -0.49
Current: -1.18

During the past 5 years, the highest EV-to-EBIT of Clene was -0.49. The lowest was -44.27. And the median was -4.03.

FRA:84C's EV-to-EBIT is ranked worse than
100% of 434 companies
in the Biotechnology industry
Industry Median: 8.915 vs FRA:84C: -1.18

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Clene's Enterprise Value for the quarter that ended in Dec. 2023 was €29.25 Mil. Clene's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-41.57 Mil. Clene's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -142.13%.


Clene EV-to-EBIT Historical Data

The historical data trend for Clene's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clene EV-to-EBIT Chart

Clene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- -26.86 -24.65 -3.13 -0.78

Clene Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.13 -4.12 -2.12 -1.48 -0.78

Competitive Comparison of Clene's EV-to-EBIT

For the Biotechnology subindustry, Clene's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clene's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clene's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Clene's EV-to-EBIT falls into.



Clene EV-to-EBIT Calculation

Clene's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=49.412/-41.567
=-1.19

Clene's current Enterprise Value is €49.41 Mil.
Clene's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-41.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clene  (FRA:84C) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Clene's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-41.567/29.245904
=-142.13 %

Clene's Enterprise Value for the quarter that ended in Dec. 2023 was €29.25 Mil.
Clene's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-41.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clene EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Clene's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Clene (FRA:84C) Business Description

Traded in Other Exchanges
Address
6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

Clene (FRA:84C) Headlines

No Headlines